))
The Future of Psychedelic Psychotherapy
Manage episode 285216592 series 2828920
Contenu fourni par Piers Kaniuka. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Piers Kaniuka ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
In Episode 14 Piers and psychedelic researcher and activist Brett Greene discuss the future of psychedelic psychotherapy. Recorded on February 6, 2021.
Brett Greene is Chief Innovation Officer of Cybin, a leading biotechnology company focused on psychedelic therapeutics. Brett was co-founder of Psymposia a non-profit media organization that offers perspectives on drugs, politics, and culture. He also was the founder of Adelia Therapeutics a biopharmaceutical company dedicated to developing psychedelic therapeutics. You can find him on LinkedIn.
Resistance Recovery (RR) is reimagining addiction, recovery, and community in the 21st century. Piers Kaniuka, MTS, MS has worked with thousands of addicts and alcoholics in his 25+ years in the field. Discover RR's new paradigm of addiction recovery by visiting Resistance Recovery.
Visit the RR YouTube channel: https://www.youtube.com/c/RESISTANCERECOVERY
Sign-up for Long Threads and get Resistance Recovery news: https://mailchi.mp/ddc8023bec67/welcometoresistancerecovery
Support this podcast at — https://redcircle.com/resistance-recovery/donations
58 episodes
Partager
